Integra LifeSciences Reaffirms Earnings View For FY17, FY18 - Quick Facts

(RTTNews) - Integra LifeSciences Holdings Corp. (IART), a medical technology company, said it continues to expect fiscal 2017 adjusted earnings per share in the range of $1.83 to $1.87 and revenues in the range of $1.165 billion to $1.175 billion, which includes about 4% organic growth.

On average, analysts polled by Thomson Reuters expect earnings of $1.85 per share on revenues of $1.17 billion for the year Analysts' estimates typically exclude special items.

Further, for fiscal 2018, the company reaffirmed adjusted earnings per share guidance in the range of $2.25 to $2.35. Analysts expect $2.3 per share.

The company also provided 2018 preliminary revenue estimate in the range of $1.46 billion to $1.48 billion, which includes about 5% organic growth. Analysts expect revenues of $1.48 billion.

The company also established five-year financial targets of approximately $2 billion in revenue and an adjusted EBITDA margin range of 28% to 30%.

The company will host an Investor Day meeting with analysts and institutional investors in New York City, beginning at 8:00 a.m. EST.